• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Oncology Pay New Positions

Quote

Anonymous

Guest
Geez rather disappointing. max out at 125/130k

You won't make any bonus cuz dam drug gonna be difficult to sell. R chop and R maintenace last 5 years +++
Very small patient population in indolent lymphoma cuz of Rituxan
If the NSD from Genetech thinks he can navigate the marketplace with this drug he gonna fail
Expectations wayyyyy too high. They will learn hard way.

THIS IS NOT RITUXAN MR. NSD. You were on the gravy train for years. Rude awakening when you actually have to sell clinically vs. other competition.
lol
Screw this gig...next
 












1st head to head data or Rituxan and or Gazyva combo data
2nd price it at half of what pharmacyclics charges so you can actually use it in combination and effectively lock out future competition
3rd manage care - shoot for a step edit
 












If you work for Gilead you will get a handjob interview and then they will pay a external candidate 2x as much as you make to take the job because they have experience.
 




Anonymous said:
If you work for Gilead you will get a handjob interview and then they will pay a external candidate 2x as much as you make to take the job because they have experience.
Click to expand...

You are probably right and if you understood anything about oncology and how difficult access is becoming,you would understand that it would be foolish for Gilead to promote a bunch of internal people that lack oncology experience and relationships.

It would be one thing if the division and products were already established and there was time for an internal hire to learn a territory and try to figure out how to see some of these guys. Unfortunately, when a company is trying to launch a new division and product into a very competitive marketplace, most reps with no experience or relationships are going to have a significant uphill battle. Ditto for managers.

I'm not trying to he a dick as I know Gilead undoubtedly has many good and qualified reps from other divisions. Just trying to point out why they are likely to go with mostly experienced, external candidates. It is what they are going to need to do to give them the best chance at a successful launch and to gain name recognition in the oncology market.
 




Your right oncology is the most difficult disease in the world and your the only genuis who can sell in this disease state! Your a dime a dozen like the rest of us and guess what you are clearly a dick serving dick sandwiches. Check your ego at the door dickface.
 








Anonymous said:
Your right oncology is the most difficult disease in the world and your the only genuis who can sell in this disease state! Your a dime a dozen like the rest of us and guess what you are clearly a dick serving dick sandwiches. Check your ego at the door dickface.
Click to expand...

Did you even read the original post? I didn't read anything about the difficulty level of the sake, just that people lije you have no relationships or knowledge of the territories. Gilead can't afford to have you guys stumbling around trying to find offices, trying to get through gatekeeoers you don't know, and selling in a disease state you are learning in the fly. If the drug had Bern out for two years, maybe, but not on a launch.

Get that chip off your shoulder, reality just bites sometimes.
 








You will fit right in at Gild with that arrogance, oncology is so hard? You are a joke, you want to sell a difficult drug come over to the Ranexa team, but it sounds like your head wouldn't fit through the door.
 




Keeping it in perspective, Ranexa is an entry level position sales job in a generic market that has a foundation of building relationships by bringing in lollipops into the offices. ONCOLOGY is very different as it has drawn parrallels to a surgical device 'close'. One has to be extremely knowledgable of the technical sell, cemented relationships for access, and the ability to have concise and rapid closes for the business. Payer landscape and a solid understanding of the complexities of reimbursement are also very important. Ischemia is NOT Oncology. Stay where you are at as I think you will be happier with the pressure that confronts you.
 




Any of this positions or disease states you are still a pharmaceutical sales rep! You are not the physician or even a nurse but a sales person who is giving a sales pitch and that's it! You must be a real scientific mind and so smart to be in sales?
 




Anonymous said:
You will fit right in at Gild with that arrogance, oncology is so hard? You are a joke, you want to sell a difficult drug come over to the Ranexa team, but it sounds like your head wouldn't fit through the door.
Click to expand...

Nor will my wallet....thanks to being an oncology rep!

I'l make over $185+ this year...you Ranexa rep doing that?

A new rep coming in to oncology will need at least two years to get in front of most docs. Those who will see you have already filled their schedules for 2014.
 












Guy is a real loser, bragging about making 185k? But he is the smartest guy in the room cause he sells one drug in oncology. You think your smart sit in a room with Norbert and test your skills out smart guy. He will fit right in with all the other short, fat, ugly reps who think they rule the world yet he has never kissed a girl.
 




Anonymous said:
Guy is a real loser, bragging about making 185k? But he is the smartest guy in the room cause he sells one drug in oncology. You think your smart sit in a room with Norbert and test your skills out smart guy. He will fit right in with all the other short, fat, ugly reps who think they rule the world yet he has never kissed a girl.
Click to expand...

Well since you Ranexa reps are already making so much money, I am sure you won't be disappointed when you are passed over in favor of reps that have relationships and knowledge of the disease state,
 




Similar threads

Pay for oncology
Replies
12
Views
5K
Gilead Sciences
Anonymous
Oncology MSL Layoffs
Replies
5
Views
1K
Gilead Sciences
anonymous
Oncology Account Director openings
Replies
14
Views
5K
Gilead Sciences
anonymous
More Oncology Assets Acquired by GILD
Replies
2
Views
2K
Gilead Sciences
anonymous
Oncology back stabbers are...
Replies
8
Views
5K
Gilead Sciences
anonymous
Top Bottom
Back
Quote